Clinical and virological properties of hepatitis C virus genotype 4 infection in patients treated with different direct-acting antiviral agents

BACKGROUND: The efficacy of direct-acting antivirals (DAAs) depends on the hepatitis C virus (HCV) genotype 4 (GT4) subtype which are used in the treatment of HCV. We aimed to retrospectively investigate the baseline prevalence of HCV NS5A and NS5B polymorphisms and their impact on virological outco...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Infect Drug Resist
Hlavní autoři: Minosse, Claudia, Selleri, Marina, Giombini, Emanuela, Bartolini, Barbara, Capobianchi, Maria Rosaria, Cerilli, Stefano, Loiacono, Laura, Taibi, Chiara, D’Offizi, Gianpiero, McPhee, Fiona, Garbuglia, AnnaRosa
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE Publications 2018
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6223400/
https://ncbi.nlm.nih.gov/pubmed/30464554
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S179158
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky